| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5677225 | Archives of Medical Research | 2016 | 15 Pages |
Abstract
HSPC abundance at initial diagnosis may aid to predict the clinical course of ALL and to identify high-risk patients. A clearer understanding of their population dynamics and functional properties in the leukemia setting will potentially pave the way for targeted therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Juan Carlos Balandrán, Eduardo Vadillo, David Dozal, Alfonso Reyes-López, Antonio Sandoval-Cabrera, Merle Denisse Laffont-Ortiz, Jessica L. Prieto-Chávez, Armando Vilchis-Ordoñez, Henry Quintela-Nuñez del Prado, Héctor Mayani,